Last update :
15/04/2024
Anticancer drug   Carmustine  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Becenun Brazil
Bicnu Australia, Canada, Chile, Colombia, France, Great Britain, Greece, Hungary, Iran, Ireland, Mexico, Morocco, New Zealand, Peru, Romania, Spain, Switzerland, Tunisia, United States of America
Bodacler Argentina
Carmubris Austria, Germany, Iran
Carmustina Grey Peru
Carmustina Perulab Peru
Carmustine Baxter New Zealand
Carmustine Obvius Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Great Britain, Hungary, Iceland, Ireland, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden
Nitrourean Spain
Nitrumon Belgium, Iran, Luxembourg
Compatibility   Injection   Compatibility : Carmustine              
This screen indicates the compatibilities or incompatibilities with, in this case, the type of incompatibility (precipitation, color change, modification of an emulsion, etc.). The compatibilities shown here are mostly physical only, with the chemical stability of each molecule rarely being assessed. The evaluation of these mixtures was studied to consider the possibility of Y-site administration to the patient. These data cannot be used for making mixtures in advance in bags or syringes. This type of information is available in the screen "Stability in mixture ».
Compound Solvent References
Chemical instability Incompatible
Injection Carmustine
NaHCO3 715
Production of gas bubbles Incompatible
Injection Carmustine 1.5 mg/ml
Injection Allopurinol sodium 3 mg/ml
Sodium chloride 0,9% 307
Compatible
Injection Carmustine 1.5 mg/ml
Injection Amifostine 10 mg/ml
Glucose 5% 3
Compatible
Injection Carmustine 1.5 mg/ml
Injection Aztreonam 40 mg/ml
Glucose 5% 99
Compatible
Injection Carmustine 1.5 mg/ml
Injection Etoposide phosphate 5 mg/ml
Glucose 5% 1410
Compatible
Injection Carmustine 1.5 mg/ml
Injection Filgrastim 30 µg/ml
Glucose 5% 244
Compatible
Injection Carmustine 1.5 mg/ml
Injection Fludarabine phosphate 1 mg/ml
Glucose 5% 492
Compatible
Injection Carmustine 1.5 mg/ml
Injection Gemcitabine hydrochloride 10 mg/ml
Sodium chloride 0,9% 1423
Compatible
Injection Carmustine 1.5 mg/ml
Injection Granisetron hydrochloride 0.05 mg/ml
Glucose 5% 182
Compatible
Injection Carmustine 1.5 mg/ml
Injection Melphalan 0.1 mg/ml
Sodium chloride 0,9% 169
Compatible
Injection Carmustine 1.5 mg/ml
Injection Ondansetron hydrochloride 1 mg/ml
Sodium chloride 0,9% 334
Compatible
Injection Carmustine 1.5 mg/ml
Injection Piperacillin sodium / tazobactam 40/5 mg/ml
Glucose 5% 81
Compatible
Injection Carmustine 1.5 mg/ml
Injection Sargramostim 10 µg/ml
Sodium chloride 0,9% 335
Chemical instability Incompatible
Injection Carmustine 0,1 mg/ml
Injection Sodium bicarbonate 84 mg/ml
NaCl 0,9% or Glucose 5% 715
Compatible
Injection Carmustine 1.5 mg/ml
Injection Teniposide 0.1 mg/ml
Glucose 5% 905
Compatible
Injection Carmustine 1.5 mg/ml
Injection Thiotepa 1 mg/ml
Glucose 5% 249
Compatible
Injection Carmustine 1.5 mg/ml
Injection Vinorelbine tartrate 1 mg/ml
Sodium chloride 0,9% 84

  Mentions Légales